Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...

LTR Pharma recently announced the dosing of the first patients in the Phase II study of SPONTAN ®, which is evaluating the safety, tolerability and pharmacokinetic profile of LTR Pharma’s rapid acting ...

Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high therapeutic efficacy.

U.S. cigarette smoking hits a record low as vaping stays widespread and nicotine pouch use grows, reshaping public health and tobacco policy.

SiBionics shared new findings about the use of AI in continuous glucose monitor (CGM) technologies at ATTD 2026.

New randomized controlled trial to evaluate dose-dependent effects of oral THC on anxiety and stress using Avicanna’s proprietary capsules ...

Financing demonstrates conviction in oligomer-selective approach and follows strong preclinical data, including in vitro, in vivo and non-human primate study results, that support development ...

Explore how paclitaxel and innovative drug delivery systems are changing cancer treatment and improving therapeutic outcomes.

For many Tanzanians seeking treatment, the journey to better health often begins at the neighbourhood pharmacy.

Tetratherix launches precision medicine franchise via Tetramatrix; signs exclusive US$3m/year deal with Superpower Health for ...

Over a median follow-up in responders of 18.0 months (range 15-21), the median duration of complete response was 18.0 months ...

Data presented at EAU 2026 show an 89 percent complete response rate in intermediate-risk disease with durable responses observed over 18 months and tolerable safety ...